POSTnote by Jonathan Wentworth. It was first published on Tuesday, 12 February 2013. It was last updated on Tuesday, 12 February 2013.
Plant-made Pharmaceuticals
The use of genetically modified (GM) plants to produce pharmaceutical drugs and vaccines is an emerging technology that offers a low-cost, large-scale alternative to current methods. This POSTnote looks at recent advances in, and the benefits of, the technology, and analyses the associated biosafety and regulatory issues.
Secondary information
- Type
- Research briefing
- Reference
- POST-PN-424
- Subjects
- Crops EU law Genetically modified organisms Drugs Plants Vaccination
- Published by
- POST
- Link
- View this Research briefing on researchbriefings.parliament.uk
Librarians' tools
- Timestamp
- 2016-02-07 22:32:43 +0000
- URI
- http://data.parliament.uk/resources/345457
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/resources/345457
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/resources/345457
- Internal location
- http://researchbriefings.intranet.parliament.uk/ResearchBriefing/Summary/POST-PN-424